Nature Medicine Accepts Manuscript Highlighting Clinical Results from the Company’s Glioblastoma Trial February 27, 2026 04:00 ET | Source: GENENTA…
MILAN and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology, today announced…